🟢 Novo Nordisk A/S is trading 4.5% up today on UAE launch of oral Wegovy pill

Novo Nordisk A/S is trading 4.5% up today at $43.88 following the launch of its oral Wegovy pill in the UAE, marking the first market outside the U.S. for this tablet formulation.

• The stock is rebounding from several down sessions as investors react positively to the expansion of the company's obesity-drug franchise.
• The UAE launch reinforces long-term growth expectations for the Wegovy brand as it scales internationally.